Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09DUE
|
||||
Former ID |
DNC007678
|
||||
Drug Name |
MCL-447
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528787] | ||
Structure |
Download2D MOL |
||||
Formula |
C22H31N3O
|
||||
Canonical SMILES |
C1CCC23CCN(C(C2C1)CC4=C3C=C(C=C4)NC(=O)N)CC5CCC5
|
||||
InChI |
1S/C22H31N3O/c23-21(26)24-17-8-7-16-12-20-18-6-1-2-9-22(18,19(16)13-17)10-11-25(20)14-15-4-3-5-15/h7-8,13,15,18,20H,1-6,9-12,14H2,(H3,23,24,26)/t18-,20+,22+/m0/s1
|
||||
InChIKey |
UYFRBZFZZCVVGT-CZTZKLFOSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Kappa-type opioid receptor | Target Info | Inhibitor | [528787] | |
Delta-type opioid receptor | Target Info | Inhibitor | [528787] | ||
Mu-type opioid receptor | Target Info | Inhibitor | [528787] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Opioid prodynorphin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Enkephalin release | |||||
Opioid proenkephalin pathway | |||||
Opioid proopiomelanocortin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.